Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Nuclear Localization Signals and Import01:46

Nuclear Localization Signals and Import

Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of  2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Nuclear Protein Sorting01:34

Nuclear Protein Sorting

Nuclear protein sorting is the selective trafficking of histones, polymerases, gene regulatory proteins into the nucleus and exporting RNAs and ribosomes to the cytosol. It is a tightly controlled process that regulates gene expression within a cell.
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Joint Localization Matters.

The Journal of rheumatology·2026
Same author

Correction: APOE4-Expressing Astrocytes Exhibit Parkinson's Disease-Related Pathology.

Molecular neurobiology·2026
Same author

Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma.

Frontiers in immunology·2026
Same author

Seven-year experience (2018-2025) of a hospital-based cardiovascular tissue bank in Israel: operational insights and clinical impact.

Cell and tissue banking·2026
Same author

Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same author

Enhancing cadaver preparation protocol to reduce bacterial contamination in musculoskeletal allografts: a comparative study of battlefield fatalities and general population donors.

Cell and tissue banking·2026

Related Experiment Video

Updated: Jun 21, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Structure-function analysis of nucleolin and ErbB receptors interactions.

Keren Farin1, Ayelet Di Segni, Adam Mor

  • 1Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel.

Plos One
|July 7, 2009
PubMed
Summary

The interaction between ErbB receptors and nucleolin is crucial for cancer growth. Specific regions of ErbB1 and nucleolin mediate this interaction, driving malignant cell proliferation and receptor activation.

More Related Videos

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Related Experiment Videos

Last Updated: Jun 21, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • ErbB receptor tyrosine kinases and nucleolin are key factors in malignant transformation.
  • Cell-surface ErbB receptors interact with nucleolin through their cytoplasmic tail.
  • Overexpression of ErbB1 and nucleolin promotes receptor phosphorylation, dimerization, and anchorage-independent growth.

Purpose of the Study:

  • To investigate the specific regions of nucleolin and ErbB involved in their interaction.
  • To elucidate the structure-function relationship governing the ErbB1-nucleolin interaction.
  • To understand how this interaction contributes to malignant cell behavior.

Main Methods:

  • Utilized mutational analyses to probe the ErbB1-nucleolin interaction.
  • Identified critical domains within ErbB1 and nucleolin responsible for binding.
  • Assessed the functional consequences of these interactions on receptor activity and cell growth.

Main Results:

  • The ErbB1 nuclear localization domain (NLS) was identified as the nucleolin-interacting region, essential for nucleolin-associated receptor activation.
  • While the tyrosine kinase domain is vital for receptor activation, it does not participate in nucleolin/ErbB binding.
  • The C-terminal 212 amino acids of nucleolin are imperative for interaction with ErbB1 and ErbB4 and can independently induce ErbB1 dimerization, phosphorylation, and anchorage-independent growth.

Conclusions:

  • Nucleolin modulates ErbB dimerization and activation, thereby enhancing cell growth and contributing to the oncogenic potential of ErbB.
  • The interaction is mediated by the nucleolin C-terminal region and the ErbB1 NLS-domain.
  • Targeting this ErbB1-nucleolin interaction may offer new therapeutic strategies for cancers driven by these proteins.